EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V for the active ingredient Interferon beta-1a (exclusively for subcutaneous application), ATC L03AB07 for the period 01.11.26-31.10.28
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1a (ausschließlich zur subkutanen Anwendung), ATC L03AB07 f. d. Z. 01.11.26-31.10.28
“Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V for the active ingredient Interferon beta-1a (exclusively for subcutaneous application), ATC L03AB07 for the period 01.11.26-31.10.28” is a eu-wide public tender. Offers are due by Wednesday, 5 September 2029, in 1039 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 September 2029, 1039 days left, 12:00
- Published
- 18 September 2026
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
Discount agreement for Interferon beta-1a for subcutaneous application for DAK-Gesundheit.
- Non-exclusive framework agreements for pharmaceutical companies.
- Contract term from 1 November 2026 to 31 October 2028.
- Accession possible at any time, documents to be submitted by email.
- Contract documents are available online for download.
- Automatic termination upon entry into force of an exclusive contract.
Summary made from the German notice and checked against it; the German original is authoritative.
Contract and procedure
| Duration | 24 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
Key points for a bid
The notice links the tender documents directly. The contract runs for 24 months.
Questions and answers
How much time is left to bid?
Until Wednesday, 5 September 2029, 1039 days left. The exact time and how to submit are in the original notice, which is authoritative.
In which language are the documents and the offer?
Usually German. The notice states the accepted languages; translations of supporting documents may be requested.
Can a company from another EU country bid?
Yes. This tender is published EU-wide, and above the EU thresholds the EU directives guarantee companies from every member state equal treatment. You submit on the platform named in the notice after registering there.
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
Timeline
| Published | Friday, 18 September 2026 |
|---|---|
| Deadline | Wednesday, 5 September 2029, 12:00 |
| Tender validity ends (calculated) | Friday, 5 October 2029 |
Service by CPV code
- 33600000 Pharmaceutical products
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.